New Appointment for Daniel P. Barboriak, M.D.

Daniel Barboriak

Daniel P. Barboriak, M.D.

Congratulations Daniel P. Barboriak, M.D., recently appointed to the Neuroscience Steering Committee of the Biomarkers Consortium.

The Biomarkers Consortium is a public-private biomedical research partnership managed by the Foundation for the National Institutes of Health that endeavors to discover, develop, and seek regulatory approval for biological markers (biomarkers) to support new drug development, preventive medicine, and medical diagnostics.”

“The consortium is helping create a new era of precision medicine, with more highly predictive markers that have an impact during a patient’s illness or lifespan. Our goal is to combine the forces of the public and private sectors to accelerate the development of biomarker-based technologies, medicines, and therapies for the prevention, early detection, diagnosis, and treatment of disease.”